IP Library Granted Patent US 9,816,076
Granted Patent B2
US 9,816,076 · App. 14/113,522 · Granted Nov 14, 2017

Protein-induced pluripotent cell technology and uses thereof

Inventors: Jianjun Wang (Troy, MI); Qianqian Li (Troy, MI)
Assignee: Wayne State University
C12N5/0696C12N2501/115C12N2501/602C12N2501/603C12N2501/604C12N2501/605C12N2501/606C12N2506/1307
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,816,076
App. No.
14/113,522
Granted
Nov 14, 2017
Kind
B2
Abstract

A method of generating protein-induced pluripotent stem cells by delivering bacterially expressed reprogramming proteins into nuclei of starting somatic cells using the QQ-protein transduction technique, repeating several cell reprogramming cycles for creating reprogrammed protein-induced pluripotent stem cells, moving the reprogrammed cells into a feeder-free medium for expansion, and expanding and passaging the reprogrammed cells in a whole dish for generating homogeneous piPS cells. Also provided are the piPCS cells formed using this method and uses thereof.

Claims (10)

1. A method of generating human protein-induced pluripotent stem cells (piPSC), comprising:

i) producing reprogramming proteins by bacterial expression, wherein the reprogramming proteins comprise the combination of Klf-4, Oct-4, Sox-2, c-myc (KOSM);

ii) modifying the bacterially expressed reprogramming proteins produced from step i) by mixing the proteins with a QQ-reagent comprising polyethylenimine (PEI) and DOTAP/DOPE;

iii) delivering the modified reprogramming proteins produced from step ii) into nuclei of starting human somatic cells, using a QQ-protein transduction technique;

iv) repeating several cell reprogramming cycles sufficient to create human reprogrammed piPSC;

v) moving the human reprogrammed piPSC from step iv into a feeder-free medium for expansion; and

vi) expanding and passaging the human reprogrammed piPSC from step v) as a whole dish of cells, with the proviso that colony picking is not performed, thereby generating homogeneous human piPSC.

2. The method according to claim 1 , further including the step of in vitro labeling the reprogramming proteins with a small molecule fluorescence probe prior to said modifying step (ii).

3. The method according to claim 2 , further including monitoring the efficiency of QQ-protein delivery into the nuclei of the starting human somatic cells.

4. The method according to claim 1 , further comprising differentiating the piPSC into a cell type selected from the group consisting of: specific adult stem cells, specific progenitor cells and a different somatic cell type compared to the starting human somatic cells.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2014
From: WANG, JIANJUN; LI, QIANQIAN
To: WAYNE STATE UNIVERSITY
Reel/Frame 032244/0802 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2014
From: WANG, JIANJUN; LI, QIANQIAN
To: WAYNE STATE UNIVERSITY
Reel/Frame 031887/0745 →
Continuity (2)
Provisional Application 61481273 · May 2, 2011
Related Publication 20140242695A1 · Aug 28, 2014